Antisense oligonucleotide (ASO) therapy for two independent targets, GREB1 and ARL4C genes.
Original method and hepatocyte reproduced hepatobiliary function
One Step N-Terminal Conjugation of Functional Compounds
Vascular endothelial stem cells (VESCs) based therapy is a promising approach for vascular regeneration.
CHRNB2, a novel target for gastric cancer, potentially other tumors
(Update): Anti-CKAP4 Monoclonal Antibody Obtained
A novel technology loosens tight junction of BBB and supports drug transportation into brain.
Useful for gene therapy by minimizing non-homologous end joining (NHEJ) derived Insertions or deletions (Indels)
Selective inhibition of Periostin variant (PN1) by monoclonal antibody
Excellent Vaccine Development/Research Platform